Researchers identify critical window for boosting immunotherapy response in prostate cancer

Researchers at Roswell Park Comprehensive Cancer Center have shown that hormone-blocking therapies commonly used to treat prostate cancers temporarily activate the body's immune response before those immune effects begin to fade over time. In a new publication in the Journal for Immunotherapy of Can